DK1257552T3 - Xanthinderivater, mellemprodukter og anvendelse til behandling af osteoporose - Google Patents
Xanthinderivater, mellemprodukter og anvendelse til behandling af osteoporoseInfo
- Publication number
- DK1257552T3 DK1257552T3 DK01907784T DK01907784T DK1257552T3 DK 1257552 T3 DK1257552 T3 DK 1257552T3 DK 01907784 T DK01907784 T DK 01907784T DK 01907784 T DK01907784 T DK 01907784T DK 1257552 T3 DK1257552 T3 DK 1257552T3
- Authority
- DK
- Denmark
- Prior art keywords
- intermediates
- osteoporosis
- treatment
- xanthine derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0001845A FR2804958B1 (fr) | 2000-02-15 | 2000-02-15 | Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant |
PCT/FR2001/000420 WO2001060824A1 (fr) | 2000-02-15 | 2001-02-14 | Derives de xanthine, intermediaires et application au traitement de l'osteoporose |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1257552T3 true DK1257552T3 (da) | 2004-12-20 |
Family
ID=8847004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01907784T DK1257552T3 (da) | 2000-02-15 | 2001-02-14 | Xanthinderivater, mellemprodukter og anvendelse til behandling af osteoporose |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1257552B1 (da) |
AT (1) | ATE273979T1 (da) |
AU (1) | AU2001235668A1 (da) |
DE (1) | DE60104986T2 (da) |
DK (1) | DK1257552T3 (da) |
ES (1) | ES2227134T3 (da) |
FR (1) | FR2804958B1 (da) |
PT (1) | PT1257552E (da) |
WO (1) | WO2001060824A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4491344B2 (ja) | 2002-06-17 | 2010-06-30 | グラクソ グループ リミテッド | 肝x受容体アゴニストとしてのプリン誘導体 |
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
AU2009204483B2 (en) | 2008-01-04 | 2014-03-13 | Intellikine, Llc | Certain chemical entities, compositions and methods |
BR112013017670B1 (pt) | 2011-01-10 | 2022-07-19 | Infinity Pharmaceuticals, Inc | Processos de preparação de isoquinolinonas e formas sólidas de isoquinolinonas |
US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
WO2015003881A1 (en) * | 2013-07-08 | 2015-01-15 | Syngenta Participations Ag | Microbiocidal heterobicyclic derivatives |
US20150320755A1 (en) | 2014-04-16 | 2015-11-12 | Infinity Pharmaceuticals, Inc. | Combination therapies |
AU2017281797A1 (en) | 2016-06-24 | 2019-01-24 | Infinity Pharmaceuticals, Inc. | Combination therapies |
CN109503583A (zh) * | 2018-12-14 | 2019-03-22 | 南京纽邦生物科技有限公司 | 1,7-二甲基黄嘌呤及其中间体的制备方法、中间体 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992006976A1 (fr) * | 1990-10-18 | 1992-04-30 | Kyowa Hakko Kogyo Co., Ltd. | Derive de xanthine |
WO1996036638A1 (en) * | 1995-05-19 | 1996-11-21 | Chiroscience Limited | Xanthines and their therapeutic use |
JPH09169665A (ja) * | 1995-12-21 | 1997-06-30 | Kenichi Miyamoto | 骨粗鬆症治療剤 |
DE59708533D1 (de) * | 1996-06-07 | 2002-11-28 | Hoechst Ag | Verwendung von Theophyllinderivaten zur Behandlung und Propylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung |
GB9703044D0 (en) * | 1997-02-14 | 1997-04-02 | Glaxo Group Ltd | Phenyl xanthine esters and amides |
JPH1192379A (ja) * | 1997-07-24 | 1999-04-06 | Kunio Takaoka | 骨疾患の予防または治療剤 |
-
2000
- 2000-02-15 FR FR0001845A patent/FR2804958B1/fr not_active Expired - Fee Related
-
2001
- 2001-02-14 ES ES01907784T patent/ES2227134T3/es not_active Expired - Lifetime
- 2001-02-14 DE DE60104986T patent/DE60104986T2/de not_active Expired - Lifetime
- 2001-02-14 AT AT01907784T patent/ATE273979T1/de active
- 2001-02-14 AU AU2001235668A patent/AU2001235668A1/en not_active Abandoned
- 2001-02-14 WO PCT/FR2001/000420 patent/WO2001060824A1/fr active IP Right Grant
- 2001-02-14 DK DK01907784T patent/DK1257552T3/da active
- 2001-02-14 EP EP01907784A patent/EP1257552B1/fr not_active Expired - Lifetime
- 2001-02-14 PT PT01907784T patent/PT1257552E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
EP1257552B1 (fr) | 2004-08-18 |
DE60104986D1 (de) | 2004-09-23 |
ATE273979T1 (de) | 2004-09-15 |
AU2001235668A1 (en) | 2001-08-27 |
PT1257552E (pt) | 2005-01-31 |
FR2804958A1 (fr) | 2001-08-17 |
WO2001060824A1 (fr) | 2001-08-23 |
ES2227134T3 (es) | 2005-04-01 |
DE60104986T2 (de) | 2005-08-25 |
FR2804958B1 (fr) | 2005-07-08 |
EP1257552A1 (fr) | 2002-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR024390A1 (es) | Nuevos compuestos | |
LU92146I2 (fr) | Dasatinib et ses sels pharmaceutiquement acceptables | |
EA200400432A1 (ru) | Производные мочевины | |
MXPA03011039A (es) | Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos. | |
PL295030A1 (en) | Method of obtaining substituted derivatives of 2-cyclohexan-1-yl amine | |
CY1105047T1 (el) | Ενωσεις πυριδοπυριμιδινονης, η μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τις περιεχουν | |
DE3373306D1 (en) | Succinimide derivatives and their production | |
CO5631438A2 (es) | Profarmacos de aminoacidos excitadores | |
DK0773943T3 (da) | Forbindelser, der er anvendelige som antiproliferative midler og garft-inhibitorer | |
SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
DK0874812T3 (da) | Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf | |
DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
DK1257552T3 (da) | Xanthinderivater, mellemprodukter og anvendelse til behandling af osteoporose | |
FI894061A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita | |
DK0450420T3 (da) | Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler | |
NO922380L (no) | Substituerte 4-fenyl-4-piperidinkarboksamider med baade lokal anestetisk og analgetisk effekt samt fremgangsmaater for deres fremstilling | |
PE20001241A1 (es) | Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores | |
BR0114380A (pt) | Derivados-1-aminobutan-3-ol-substituìdos | |
DK0625153T3 (da) | Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf | |
NO20002600D0 (no) | Mellomprodukter og fremgangsmÕter for anvendelse ved semisyntesen av paclitaxel og analoger | |
DK0606175T3 (da) | 2-cyan-3-hydroxypropenamider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler samt farmaceutiske præparater med indhold deraf | |
MXPA03008248A (es) | Agentes colorantes para fibras de queratina que contienen derivados de n-heteroarilmetil-m-fenilendiamina, asi como nuevos derivados de n-heteroarilmetil-m-fenilendiamina. | |
MXPA02001406A (es) | Heterociclilos-2h-cromenos substituidos. | |
DE3866292D1 (de) | Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
CR6503A (es) | Derivados de- 1-trifluorometil-4-hidroxi-7-piperidinil-aminometiclcromano |